Skip to content

Love Infection: A Dramatized Story Intervention (Telenovela/Soap Opera) for HIV Prevention

Infección de Amor (Love Infection): Online Delivery and Pilot Testing of a Dramatized Story Intervention (Telenovela/Soap Opera) for HIV Prevention Among Latinas in North Carolina

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05358366
Acronym
IA
Enrollment
58
Registered
2022-05-03
Start date
2022-05-10
Completion date
2023-04-30
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections

Keywords

HIV, Latinas, Primary Disease Prevention, Internet Based Intervention

Brief summary

Purpose: To test the feasibility, acceptability of the IA intervention (four telenovela episodes), assessment of the mechanisms of action (self-efficacy, narrative engagement, and emotional elicitation) and conduct a randomized controlled pilot study to examine the change in primary outcomes (condom use, HIV testing, Pre-exposure Prophylaxis (PrEP) awareness and use) and secondary outcomes (Substance abuse (SA), intimate partner violence (IPV), and depression comparing 33 intervention- and 33 control Latinas at baseline (T1, pre-intervention), T2 (immediately post-intervention, 1 month) and T3 (3 months after the end of the intervention, with no intervening contact with study staff). Participants: 66 Latinas ages 18-44 years who report sexual activity with a man in the last 6 months, have internet access from any device, and reside in NC. Procedures (methods): Participants will be asked to: (1) receive an orientation about the use of the Infección de Amor (IA) telenovela website and access the telenovela website once a week for 4 weeks to watch a telenovela episode and answer some questions about the episode (half hour each week, 2 in total), (2) attend to a one hour-meeting with the research team to complete a baseline survey, (3) complete a survey (on their own) one-month after the baseline survey, and (4) complete another survey (on their own) 4-months after the baseline survey. Participants will complete a structured survey in the first meeting (baseline survey) with a member of the research team and then they will complete the follow-up surveys (1-month and 4-months after baseline) on their own. Participants can request help to complete these surveys with the help of the research team (online using Zoom or face to face if needed). The moment that participants will access the IA intervention will depend on the group to be assigned by the research team (intervention or control group).

Detailed description

Background Information Latinas continue to be affected disproportionally by HIV in the US.1 In 2017, Latinas accounted for 16% of new HIV diagnoses infection among women, a rate four-fold that of White women. To address this marked disparity, an innovative intervention - a filmed dramatized story (telenovela/soap opera) Infección de Amor (IA), or Love Infection - culturally tailored for US Latinas and delivered online is proposed in this study. IA is a four-episode HIV prevention telenovela co-created with Latinas and a community-based participatory and interdisciplinary. IA emphasizes the influence of romantic relationships in HIV infection and is available in Spanish and English. The development of IA incorporated the National Institute on Minority Health and Health Disparities (NIMHD) Framework, conceptualizing factors relevant to the understanding and promotion of minority health and understanding and reducing health disparities, to guide its content. Social cognitive theory, narrative engagement theory, and research on emotional responses are the mechanisms of action-guiding IA's delivery. Participants A total of 66 Latinas ages 18-44 years who report sexual activity with a man in the last 6 months, have internet access from any device, and reside in NC. Recruitment and screening will be led by a bilingual (English and Spanish) study personnel. Participants will be asked their preferred language at the time of recruitment. All study materials, including information and consent forms, questionnaires, and recruitment ads, will be translated and available in Spanish. Any direct interaction with non-English-speaking participants will be available in Spanish Study procedures The research team is bilingual and will be able to assist women if they have questions about the study. Study procedures will be conducted in English and/or Spanish according to participant's preference. A screening form to see if a person qualifies for the study that is available in Qualtrics will be used. If the person qualifies for the study, a first meeting to conduct the baseline survey will be arranged with the research team. \- Baseline survey. If potential participants meet the inclusion criteria, they will be asked to attend to a one hour-meeting with a member of the research team to sign the informed consent, complete a baseline survey and receive an orientation about the use of the telenovela website https://www.infecciondeamor.com/. After participants complete the survey, they will be randomized by a member of the research team to the intervention or control group. The research team member will explain the following activities they have to complete according to the group they will be assigned. If they are randomized to the control group, the orientation to the website will be delayed until they complete the 4-month post baseline survey. The survey will be available in Qualtrics and only the members of the research team will have access to the survey. After completing the baseline survey, participants will be randomized to the intervention or control groups by a computer-generated randomization table, using blocking of participants to ensure a balance between groups. An envelope will contain the result of the randomization and the assessors will open this envelop in front of the participant after she finished the baseline survey. Each participants envelop will be assigned based on the ID number (e.g., 1, 2, 3) \- Intervention group: Latinas will view four IA intervention episodes, one per week. Participants will receive an email to their preferred email address with a password to access to the episode on the IA's website: https://www.infecciondeamor.com/ Each 10-minute episode can be watched more than once during the week and presents a situation with notable HIV risk and ways the characters avoided risk (e.g., condom use) or confronted consequences of poor practices (e.g., HIV infection). After each episode, participants will complete a survey (on their own) on Qualtrics. This post episode survey includes questions about the mechanisms of action of the telenovela (self-efficacy, narrative engagement, and emotional elicitation). * Control group: A wait-listed control group of 33 Latinas will receive IA in the same manner as the intervention group after completing T3 data collection. During the waiting time, participants will be contacted on a monthly basis to encourage participation and refer to services if needed. * Follow-up surveys. Participants will answer a (one-month after baseline) survey, and complete another survey (on their own) 4 months after baseline. Participants will complete these surveys (1-month and 4-months after baseline) on their own. Participants can request help to complete these surveys (online using zoom or face to face if needed). * Infección de Amor website. The website provides: a) access to the four intervention episodes 24/7 from any location or type of device (e.g., cellphone, laptop) since is mobile optimized (all the episodes are password protected); b) questionnaires for data collection deployed via Qualtrics; c) a contact section; and d) a section with community resources, services, and referrals. Secure and private servers and communication channels such as OneDrive will be used to store and to exchange information. A new episode of IA will be available each week. Women can watch an episode as many times as they want during the week, but they need to answer a post episode-viewing survey after viewing it the first time. Also, they will be able to pause or stop the episodes at any time if they need to take a break or stop watching for any reason. Women will be advised to watch the episodes alone. Prior episodes will remain available after a new episode is released. Participants will receive reminders about completion of the surveys using an automated notification system from Qualtrics. In addition, up to three reminders (e.g., phone, email) will be sent each week to participants who have not accessed an episode in a specific window period and completed the post episode survey or if the participant has not access to the website in one week. If a woman does not complete the episode in one week or does not access the website in one week, the research team will contact the participant to her preferred email or phone. The research team will discuss with her any impediments to her participation, how to watch the missed episode, and resume with the following episodes. Women will be able to pause or stop the episodes at any time if they need it. Prior episodes will remain available after a new episode is released if women would like to review them. \- Procedures for Minority Retention and Potential Challenges. The website will track if participants watched the whole episode. Each episode also contains information about HIV prevention at the end and a link to the technical support and referrals sections if needed. Other retention strategies will include: 1) updating contact information frequently; 2) requesting contact information of at least two friends or relatives; 3) contacting the woman by email or cell phone (permission to contact the participants will be requested in the informed consent); 4) providing compensation for their time, internet use, and transportation; and 5) automated notification system messages for special occasions (e.g., holidays). Attrition will be monitored in both conditions. Potential issues with Latinas and community centers, and if needed, establish a community advisory board of three Latinas of the same age as those participating in the study to ask for their advice. Follow-up procedures Participants will have access to watch the intervention online individually 24/7 from their preferred location. They will be asked to watch the intervention in a comfortable and private place since some of the content (e.g., IPV, substance use) can be sensitive for them or other people (e.g., their children) if they allow them to watch. Participants will have a contact section on the online platform in case they have questions, they need referrals, or they want to talk about issues that may arise while they are watching the telenovela. If they are watching the telenovela and they experience stress or anxiety, they will be instructed to call a person from the team who will be available to listen to them and refer them to proper services if needed. The person from the team will notify the PI about the situation and how it should be managed. A protocol will be created by the research team to manage these situations. Latinas will be instructed that they can stop their participation at that moment and that this situation will not affect their ability to continue in the study. Potential risks The research team will treat Latinas with respect and will be sensitive if they express that they feel or voice embarrassment with the intervention content. The research team will explain to them that this will not affect their ability to continue in the study. If a potential breach of confidentiality occurs, which could be related with someone finding out that a participant is involved in the study or if a study member unintentionally disclosures confidential information about the participants. Efforts will be made to avoid these situations, by not revealing any information about participants to any people external to the research unless requested by authorities. Participants will be requested to keep their randomization to the groups (intervention or control) confidential. In addition, all the team members will have their Human subject training up to date and will receive a training to avoid situations that can lead to breach in confidentiality. . Referrals El Futuro is a community center who provides mental health services to the Latino population. El Futuro will provide the space for the study related activities and will facilitate recruitment (flyers). In need of a referral, participants will be advised to call to this community center. A list of referrals to other community centers that provide culturally sensitive services in case they need other type of services (e.g., HIV test) will also be provided. The Investigators will be responsible for ensuring that study protocols for maintaining confidentiality are followed. The PI will provide ongoing supervision and training to essential study staff at weekly meetings, which will also ensure continued compliance with data safety protocols.

Interventions

BEHAVIORALInfeccion de Amor (Love Infection)

Love Infection is a filmed dramatized story (telenovela/soap opera) Infección de Amor (IA), or Love Infection - culturally tailored for US Latinas and delivered online. IA is a four-episode HIV prevention telenovela co-created with Latinas and a community-based participatory and interdisciplinary. Participants have one week window to watch the 10-minute episodes from their preferred device and location.

Sponsors

North Carolina Translational and Clinical Sciences Institute
CollaboratorOTHER
University of North Carolina, Chapel Hill
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

2 arms, intervention and wait-listed control group. Participants in the intervention group will receive the 4 episodes of the Love infection intervention (one episode weekly) after the baseline assessment. Participants in the wait-listed control group will receive the intervention after completing the 3-month assessment.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 44 Years
Healthy volunteers
Yes

Inclusion criteria

* Self-identified as a Latina * Assigned female gender at birth * Fluent in English or Spanish * Between 18 and 44 years old * Report sexual activity with a man in the last 6 months * Have internet access from any device * Reside in NC

Exclusion criteria

* Unwilling to be part of the study * Do not read, speak, or understand Spanish or English * Do not have access to internet * HIV positive

Design outcomes

Primary

MeasureTime frameDescription
Mean Condom Usebaseline up to 4 monthsCondom use will be measured as the number of sexual episodes (oral, vaginal, or anal intercourse) in which condoms were used with a male partner in the last month.
Mean Change in HIV Test Perception Scorebaseline up to 4 monthsChanges in HIV testing perception will be measured with the willingness to take an HIV test measure scale. Scores range from 9-45. A higher score represents a higher willingness to take an HIV test.
Number of Participants Who Report Change in HIV Testingbaseline up to 4 monthsChanges in HIV testing will be measured as the number of participants who reported to have been tested for HIV in the last month.
Number of Participants Who Report Changes in PrEP Usebaseline to 4 monthsChanges in PrEP use will be measured as the number of participants who report that they have used PrEP (dichotomous question: yes/no). Those participants who answered Yes to the PrEP awareness question were asked about PrEP use.
Number of Participants Who Report Change in PrEP Accessbaseline to 4 monthsChanges in PrEP access will be measured as the number of participants who report that they have access to PrEP (Possible responses: yes/no/don't know). Those participants who answered Yes to the PrEP awareness question were asked if they have access to PrEP.
Number of Participants Who Report Change in PrEP AwarenessBaseline up to 4 monthsChanges in PrEP awareness will be measured as the number of participants who self-report whether they know about PrEP medication (dichotomous question: yes/no)

Secondary

MeasureTime frameDescription
Mean Change in Intimate Partner Violence (IPV) Scorebaseline up to 4 monthsChanges in IPV measured using the revised Conflict Tactics Scale to measure women's self-reported IPV in the previous 3 months (e.g., your partner insulted you). Scores range from 0-36 points. A higher score indicates higher levels of IPV.
Mean Change in Substance Abuse Scorebaseline up to 4 monthsChanges in substance abuse will be measured with the Substance abuse behaviors scale. Scores range from 0-35. A higher score represents a higher use of substances.
Mean Change in Depression (PHQ-9) Scorebaseline up to 4 monthsChanges in depression will be measured with the Patient Health Questionnaire (PHQ-9), a 9-item scale commonly used for depression screening in primary care and other health settings. Scores range from 0-27. A higher score indicates more depressive symptoms.
Number of Episodes Watched by Participantsimmediately after watching each 10-minute weekly episode for up to 4 weeksThe online website will track if the 40-minutes of the intervention content is viewed and the number of participants who complete of all content will be calculated.
Number of Participants Who Are Retained Through All Study Timepointsbaseline up to 4 monthsThe number of participants who completed all study assessment timepoints from start to finish.

Other

MeasureTime frameDescription
Change in Narrative Engagementbaseline up to 1 monthNarrative engagement will be measured with the Perception of Narrative Performance Scale, which measures three dimensions of engagement: interest, realism, and identification. Scores range from 9-36. A higher score indicates a higher level of engagement.
Change in Self-Efficacy for HIV Preventionbaseline up to 1 monthChanges in Self-Efficacy will be measured using the HIV self-efficacy for HIV prevention behaviors survey. Scores range from 11-55. A higher score indicates a higher level of self-efficacy for HIV prevention behaviors.
Change in Self-Efficacy for Condom Usebaseline up to 1 monthChanges in Self-Efficacy will be measured using the HIV self-efficacy for condom use survey. Scores range from 7-28. A higher score indicates a higher level of self-efficacy for condom use.
Changes in HIV Knowledgebaseline up to 4 monthsChange in HIV knowledge will be measured via the HIV Knowledge Scale. The score ranges from 0-12 with a higher score indicating a higher level of HIV-related knowledge.
Feasibility of the Interventionbaseline up to 4 monthsMeasured as the total number of sessions attended by the participants as a whole.
Changes in STI (Sexually Transmitted Infections) Testingbaseline up to 4 monthsChanges in STI testing will be measured as the number of participants who reported to have been tested for a STI in the last month.
Changes in Sexual Communication With Partnerbaseline up to 4 monthsChange in sexual communication with partner will be measured via the Partner communication Scale (Catania et al., 1995). The score ranges from 0-10 with a higher score indicating a higher level of partner communication.
Change in Emotional Responsebaseline up to 1 monthChanges in emotional Response will be measured with the International Positive and Negative Affect Schedule Short Form (I-PANAS-SF). Scores range from 10-50. The higher scores indicate the tendency to experience a positive and negative mood.
Mean Participant Acceptability With the Intervention Content Areas Based on a 5 Point Rating Systemone-month after the baseline surveyParticipants will be asked to rate each of the 9 content area using a 5-star rating system where 1 star is the lowest and 5 points is the highest rating. A mean of all ratings will be calculated. The closer the mean is to 5.0, the higher the satisfaction with the content areas. Scores range from 9-45. A higher score indicates a higher level of acceptability.

Countries

United States

Participant flow

Participants by arm

ArmCount
Infeccion de Amor (Infectious Love)
Participants will view four IA intervention episodes, one per week starting immediately after the baseline survey and orientation. Participants will receive an email to their preferred email address with a password to access the episode on the IA's website: https://www.infecciondeamor.com. Each 10-minute episode can be watched more than once during the week and presents a situation with notable HIV risk and ways the characters avoided risk (e.g., condom use) or confronted consequences of poor practices (e.g., HIV infection).
31
Wait-listed
Participants will receive IA in the same manner as the intervention group. Participants will start watching the telenovela episodes 4 months after their baseline survey (after T3 survey). Participants will be informed at recruitment of this group condition and the study randomization. During the waiting time, participants will be called on a monthly basis to encourage participation and refer to services if needed. Infeccion de Amor (Infectious Love): Infectious Love is a filmed dramatized story (telenovela/soap opera) Infección de Amor (IA), or Infectious Love - culturally tailored for US Latinas and delivered online. IA is a four-episode HIV prevention telenovela co-created with Latinas and a community-based participatory and interdisciplinary. Participants have one week window to watch the 10-minute episodes from their preferred device and location.
27
Total58

Baseline characteristics

CharacteristicInfeccion de Amor (Infectious Love)TotalWait-listed
Age, Continuous33.26 years34.71 years36.37 years
Ethnicity (NIH/OMB)
Hispanic or Latino
31 Participants58 Participants27 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
13 Participants28 Participants15 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants2 Participants2 Participants
Race (NIH/OMB)
Unknown or Not Reported
3 Participants4 Participants1 Participants
Race (NIH/OMB)
White
15 Participants23 Participants8 Participants
Region of Enrollment
United States
31 Participants58 Participants27 Participants
Sex: Female, Male
Female
31 Participants58 Participants27 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 310 / 27
other
Total, other adverse events
0 / 310 / 27
serious
Total, serious adverse events
0 / 310 / 27

Outcome results

Primary

Mean Change in HIV Test Perception Score

Changes in HIV testing perception will be measured with the willingness to take an HIV test measure scale. Scores range from 9-45. A higher score represents a higher willingness to take an HIV test.

Time frame: baseline up to 4 months

Population: Participants were asked to complete the HIV Test Perception Score at each timepoint although some participants did not do so each time. Data are reported for all completed questionnaires.

ArmMeasureGroupValue (MEAN)Dispersion
Infeccion de Amor (Infectious Love)Mean Change in HIV Test Perception ScoreBaseline34.7 score on a scaleStandard Deviation 3.83
Infeccion de Amor (Infectious Love)Mean Change in HIV Test Perception ScoreMonth 134.6 score on a scaleStandard Deviation 3.37
Infeccion de Amor (Infectious Love)Mean Change in HIV Test Perception ScoreMonth 432.8 score on a scaleStandard Deviation 5.82
Wait-listedMean Change in HIV Test Perception ScoreBaseline35.7 score on a scaleStandard Deviation 4.07
Wait-listedMean Change in HIV Test Perception ScoreMonth 136.4 score on a scaleStandard Deviation 3.25
Wait-listedMean Change in HIV Test Perception ScoreMonth 436.1 score on a scaleStandard Deviation 4.33
Primary

Mean Condom Use

Condom use will be measured as the number of sexual episodes (oral, vaginal, or anal intercourse) in which condoms were used with a male partner in the last month.

Time frame: baseline up to 4 months

Population: No Infeccion de Amor (Infectious Love) participants reported engaging in anal intercourse at baseline. Month 1 data are reported for those in this group who completed Follow-Up 1 assessment (immediately after intervention period completion). Wait-listed participants completed Month 1 assessment before watching intervention (4 months after baseline). Month 4 data are reported for each arm for those who completed the second Follow-Up.

ArmMeasureGroupValue (MEAN)Dispersion
Infeccion de Amor (Infectious Love)Mean Condom UseMonth 1 Anal Intercourse0 sexual episodesStandard Deviation 0
Infeccion de Amor (Infectious Love)Mean Condom UseBaseline Vaginal1.30 sexual episodesStandard Deviation 2.562
Infeccion de Amor (Infectious Love)Mean Condom UseMonth 4 Oral0 sexual episodesStandard Deviation 0
Infeccion de Amor (Infectious Love)Mean Condom UseMonth 1 Vaginal1.50 sexual episodesStandard Deviation 2.526
Infeccion de Amor (Infectious Love)Mean Condom UseMonth 4 Vaginal2.25 sexual episodesStandard Deviation 2.933
Infeccion de Amor (Infectious Love)Mean Condom UseMonth 1 Oral0 sexual episodesStandard Deviation 0
Infeccion de Amor (Infectious Love)Mean Condom UseMonth 4 Anal Intercourse0 sexual episodesStandard Deviation 0
Infeccion de Amor (Infectious Love)Mean Condom UseBaseline Oral0.50 sexual episodesStandard Deviation 1.414
Wait-listedMean Condom UseMonth 4 Vaginal1.75 sexual episodesStandard Deviation 3.768
Wait-listedMean Condom UseMonth 4 Anal Intercourse0 sexual episodesStandard Deviation 0
Wait-listedMean Condom UseBaseline Oral0.14 sexual episodesStandard Deviation 0.535
Wait-listedMean Condom UseBaseline Vaginal0.52 sexual episodesStandard Deviation 1.159
Wait-listedMean Condom UseBaseline Anal Intercourse0 sexual episodesStandard Deviation 0
Wait-listedMean Condom UseMonth 1 Oral1.25 sexual episodesStandard Deviation 2.927
Wait-listedMean Condom UseMonth 1 Vaginal1.43 sexual episodesStandard Deviation 2.243
Wait-listedMean Condom UseMonth 1 Anal Intercourse3.00 sexual episodesStandard Deviation 0
Wait-listedMean Condom UseMonth 4 Oral0.09 sexual episodesStandard Deviation 0.302
Primary

Number of Participants Who Report Change in HIV Testing

Changes in HIV testing will be measured as the number of participants who reported to have been tested for HIV in the last month.

Time frame: baseline up to 4 months

Population: This question was only asked of participants who indicated having had a previous HIV test within 30 days before study entry.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Infeccion de Amor (Infectious Love)Number of Participants Who Report Change in HIV TestingBaseline-Yes6 Participants
Infeccion de Amor (Infectious Love)Number of Participants Who Report Change in HIV TestingBaseline-No19 Participants
Infeccion de Amor (Infectious Love)Number of Participants Who Report Change in HIV TestingMonth 1-Yes3 Participants
Infeccion de Amor (Infectious Love)Number of Participants Who Report Change in HIV TestingMonth 1-No20 Participants
Infeccion de Amor (Infectious Love)Number of Participants Who Report Change in HIV TestingMonth 4-Yes3 Participants
Infeccion de Amor (Infectious Love)Number of Participants Who Report Change in HIV TestingMonth 4-No21 Participants
Wait-listedNumber of Participants Who Report Change in HIV TestingMonth 4-Yes4 Participants
Wait-listedNumber of Participants Who Report Change in HIV TestingBaseline-Yes3 Participants
Wait-listedNumber of Participants Who Report Change in HIV TestingMonth 1-No15 Participants
Wait-listedNumber of Participants Who Report Change in HIV TestingBaseline-No21 Participants
Wait-listedNumber of Participants Who Report Change in HIV TestingMonth 4-No17 Participants
Wait-listedNumber of Participants Who Report Change in HIV TestingMonth 1-Yes2 Participants
Primary

Number of Participants Who Report Change in PrEP Access

Changes in PrEP access will be measured as the number of participants who report that they have access to PrEP (Possible responses: yes/no/don't know). Those participants who answered Yes to the PrEP awareness question were asked if they have access to PrEP.

Time frame: baseline to 4 months

Population: The Overall Number of Participants Analyzed reflects the number of unique participants who provided data for any single timepoint. Participants were asked to provide a response at each timepoint although some participants did not provide a response each time they were asked. Data are reported for all responses received.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Infeccion de Amor (Infectious Love)Number of Participants Who Report Change in PrEP AccessBaseline-No4 Participants
Infeccion de Amor (Infectious Love)Number of Participants Who Report Change in PrEP AccessMonth 1--Don't Know9 Participants
Infeccion de Amor (Infectious Love)Number of Participants Who Report Change in PrEP AccessMonth 1-Yes2 Participants
Infeccion de Amor (Infectious Love)Number of Participants Who Report Change in PrEP AccessMonth 4-Yes5 Participants
Infeccion de Amor (Infectious Love)Number of Participants Who Report Change in PrEP AccessBaseline-Don't Know1 Participants
Infeccion de Amor (Infectious Love)Number of Participants Who Report Change in PrEP AccessMonth 4-No4 Participants
Infeccion de Amor (Infectious Love)Number of Participants Who Report Change in PrEP AccessMonth 1-No9 Participants
Infeccion de Amor (Infectious Love)Number of Participants Who Report Change in PrEP AccessMonth 4--Don't Know7 Participants
Infeccion de Amor (Infectious Love)Number of Participants Who Report Change in PrEP AccessBaseline-Yes2 Participants
Wait-listedNumber of Participants Who Report Change in PrEP AccessMonth 4--Don't Know1 Participants
Wait-listedNumber of Participants Who Report Change in PrEP AccessBaseline-Yes0 Participants
Wait-listedNumber of Participants Who Report Change in PrEP AccessBaseline-No1 Participants
Wait-listedNumber of Participants Who Report Change in PrEP AccessBaseline-Don't Know1 Participants
Wait-listedNumber of Participants Who Report Change in PrEP AccessMonth 1-Yes0 Participants
Wait-listedNumber of Participants Who Report Change in PrEP AccessMonth 1-No0 Participants
Wait-listedNumber of Participants Who Report Change in PrEP AccessMonth 1--Don't Know1 Participants
Wait-listedNumber of Participants Who Report Change in PrEP AccessMonth 4-Yes0 Participants
Wait-listedNumber of Participants Who Report Change in PrEP AccessMonth 4-No1 Participants
Primary

Number of Participants Who Report Change in PrEP Awareness

Changes in PrEP awareness will be measured as the number of participants who self-report whether they know about PrEP medication (dichotomous question: yes/no)

Time frame: Baseline up to 4 months

Population: Data are reported for all participants who reported this information.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Infeccion de Amor (Infectious Love)Number of Participants Who Report Change in PrEP AwarenessBaseline-No24 Participants
Infeccion de Amor (Infectious Love)Number of Participants Who Report Change in PrEP AwarenessMonth 1-No6 Participants
Infeccion de Amor (Infectious Love)Number of Participants Who Report Change in PrEP AwarenessBaseline-Yes7 Participants
Infeccion de Amor (Infectious Love)Number of Participants Who Report Change in PrEP AwarenessMonth 4-Yes16 Participants
Infeccion de Amor (Infectious Love)Number of Participants Who Report Change in PrEP AwarenessMonth 1-Yes20 Participants
Infeccion de Amor (Infectious Love)Number of Participants Who Report Change in PrEP AwarenessMonth 4-No9 Participants
Wait-listedNumber of Participants Who Report Change in PrEP AwarenessMonth 1-Yes1 Participants
Wait-listedNumber of Participants Who Report Change in PrEP AwarenessBaseline-Yes2 Participants
Wait-listedNumber of Participants Who Report Change in PrEP AwarenessBaseline-No25 Participants
Wait-listedNumber of Participants Who Report Change in PrEP AwarenessMonth 4-No20 Participants
Wait-listedNumber of Participants Who Report Change in PrEP AwarenessMonth 1-No23 Participants
Wait-listedNumber of Participants Who Report Change in PrEP AwarenessMonth 4-Yes2 Participants
Primary

Number of Participants Who Report Changes in PrEP Use

Changes in PrEP use will be measured as the number of participants who report that they have used PrEP (dichotomous question: yes/no). Those participants who answered Yes to the PrEP awareness question were asked about PrEP use.

Time frame: baseline to 4 months

Population: The Overall Number of Participants Analyzed reflects the number of unique participants who provided data for any single timepoint. Participants were asked to provide a response at each timepoint although some participants did not provide a response each time they were asked. Data are reported for all responses received.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Infeccion de Amor (Infectious Love)Number of Participants Who Report Changes in PrEP UseBaseline-Yes0 Participants
Infeccion de Amor (Infectious Love)Number of Participants Who Report Changes in PrEP UseBaseline-No7 Participants
Infeccion de Amor (Infectious Love)Number of Participants Who Report Changes in PrEP UseMonth 1-Yes0 Participants
Infeccion de Amor (Infectious Love)Number of Participants Who Report Changes in PrEP UseMonth 1-No20 Participants
Infeccion de Amor (Infectious Love)Number of Participants Who Report Changes in PrEP UseMonth 4-Yes0 Participants
Infeccion de Amor (Infectious Love)Number of Participants Who Report Changes in PrEP UseMonth 4-No16 Participants
Wait-listedNumber of Participants Who Report Changes in PrEP UseMonth 4-Yes0 Participants
Wait-listedNumber of Participants Who Report Changes in PrEP UseBaseline-Yes0 Participants
Wait-listedNumber of Participants Who Report Changes in PrEP UseMonth 1-No1 Participants
Wait-listedNumber of Participants Who Report Changes in PrEP UseBaseline-No2 Participants
Wait-listedNumber of Participants Who Report Changes in PrEP UseMonth 4-No2 Participants
Wait-listedNumber of Participants Who Report Changes in PrEP UseMonth 1-Yes0 Participants
Secondary

Mean Change in Depression (PHQ-9) Score

Changes in depression will be measured with the Patient Health Questionnaire (PHQ-9), a 9-item scale commonly used for depression screening in primary care and other health settings. Scores range from 0-27. A higher score indicates more depressive symptoms.

Time frame: baseline up to 4 months

Population: Participants were asked to complete the PHQ-9 at each timepoint although some participants did not do so each time. Data are reported for all completed questionnaires.

ArmMeasureGroupValue (MEAN)Dispersion
Infeccion de Amor (Infectious Love)Mean Change in Depression (PHQ-9) ScoreBaseline5.61 score on a scaleStandard Deviation 3.97
Infeccion de Amor (Infectious Love)Mean Change in Depression (PHQ-9) ScoreMonth 15.65 score on a scaleStandard Deviation 4.36
Infeccion de Amor (Infectious Love)Mean Change in Depression (PHQ-9) ScoreMonth 46.67 score on a scaleStandard Deviation 6.4
Wait-listedMean Change in Depression (PHQ-9) ScoreBaseline4.04 score on a scaleStandard Deviation 4.05
Wait-listedMean Change in Depression (PHQ-9) ScoreMonth 12.29 score on a scaleStandard Deviation 3.34
Wait-listedMean Change in Depression (PHQ-9) ScoreMonth 42.36 score on a scaleStandard Deviation 2.92
Secondary

Mean Change in Intimate Partner Violence (IPV) Score

Changes in IPV measured using the revised Conflict Tactics Scale to measure women's self-reported IPV in the previous 3 months (e.g., your partner insulted you). Scores range from 0-36 points. A higher score indicates higher levels of IPV.

Time frame: baseline up to 4 months

Population: Participants were asked to complete the IPV at each timepoint although some participants did not do so each time. Data are reported for all completed questionnaires.

ArmMeasureGroupValue (MEAN)Dispersion
Infeccion de Amor (Infectious Love)Mean Change in Intimate Partner Violence (IPV) ScoreBaseline2.27 score on a scaleStandard Deviation 3.52
Infeccion de Amor (Infectious Love)Mean Change in Intimate Partner Violence (IPV) ScoreMonth 12.28 score on a scaleStandard Deviation 5.56
Infeccion de Amor (Infectious Love)Mean Change in Intimate Partner Violence (IPV) ScoreMonth 41.79 score on a scaleStandard Deviation 3.72
Wait-listedMean Change in Intimate Partner Violence (IPV) ScoreBaseline2.78 score on a scaleStandard Deviation 4.57
Wait-listedMean Change in Intimate Partner Violence (IPV) ScoreMonth 11.96 score on a scaleStandard Deviation 3.26
Wait-listedMean Change in Intimate Partner Violence (IPV) ScoreMonth 41.25 score on a scaleStandard Deviation 1.83
Secondary

Mean Change in Substance Abuse Score

Changes in substance abuse will be measured with the Substance abuse behaviors scale. Scores range from 0-35. A higher score represents a higher use of substances.

Time frame: baseline up to 4 months

Population: Participants were asked to complete the Substance Abuse Behaviors Scale at each timepoint although some participants did not do so each time. Data are reported for all completed questionnaires.

ArmMeasureGroupValue (MEAN)Dispersion
Infeccion de Amor (Infectious Love)Mean Change in Substance Abuse ScoreBaseline2.42 score on a scaleStandard Deviation 3.65
Infeccion de Amor (Infectious Love)Mean Change in Substance Abuse ScoreMonth 12.32 score on a scaleStandard Deviation 3.78
Infeccion de Amor (Infectious Love)Mean Change in Substance Abuse ScoreMonth 42.75 score on a scaleStandard Deviation 3.67
Wait-listedMean Change in Substance Abuse ScoreBaseline0.78 score on a scaleStandard Deviation 1.09
Wait-listedMean Change in Substance Abuse ScoreMonth 10.96 score on a scaleStandard Deviation 1.3
Wait-listedMean Change in Substance Abuse ScoreMonth 41.23 score on a scaleStandard Deviation 2.86
Secondary

Number of Episodes Watched by Participants

The online website will track if the 40-minutes of the intervention content is viewed and the number of participants who complete of all content will be calculated.

Time frame: immediately after watching each 10-minute weekly episode for up to 4 weeks

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Infeccion de Amor (Infectious Love)Number of Episodes Watched by ParticipantsWatched 1 Episodes1 Participants
Infeccion de Amor (Infectious Love)Number of Episodes Watched by ParticipantsWatched 3 Episodes0 Participants
Infeccion de Amor (Infectious Love)Number of Episodes Watched by ParticipantsWatched 2 Episodes2 Participants
Infeccion de Amor (Infectious Love)Number of Episodes Watched by ParticipantsWatched 4 Episodes26 Participants
Infeccion de Amor (Infectious Love)Number of Episodes Watched by ParticipantsWatched 0 Episodes2 Participants
Wait-listedNumber of Episodes Watched by ParticipantsWatched 4 Episodes7 Participants
Wait-listedNumber of Episodes Watched by ParticipantsWatched 0 Episodes18 Participants
Wait-listedNumber of Episodes Watched by ParticipantsWatched 1 Episodes2 Participants
Wait-listedNumber of Episodes Watched by ParticipantsWatched 2 Episodes0 Participants
Wait-listedNumber of Episodes Watched by ParticipantsWatched 3 Episodes0 Participants
Secondary

Number of Participants Who Are Retained Through All Study Timepoints

The number of participants who completed all study assessment timepoints from start to finish.

Time frame: baseline up to 4 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Infeccion de Amor (Infectious Love)Number of Participants Who Are Retained Through All Study Timepoints26 Participants
Wait-listedNumber of Participants Who Are Retained Through All Study Timepoints23 Participants
Other Pre-specified

Change in Emotional Response

Changes in emotional Response will be measured with the International Positive and Negative Affect Schedule Short Form (I-PANAS-SF). Scores range from 10-50. The higher scores indicate the tendency to experience a positive and negative mood.

Time frame: baseline up to 1 month

Other Pre-specified

Change in Narrative Engagement

Narrative engagement will be measured with the Perception of Narrative Performance Scale, which measures three dimensions of engagement: interest, realism, and identification. Scores range from 9-36. A higher score indicates a higher level of engagement.

Time frame: baseline up to 1 month

Other Pre-specified

Change in Self-Efficacy for Condom Use

Changes in Self-Efficacy will be measured using the HIV self-efficacy for condom use survey. Scores range from 7-28. A higher score indicates a higher level of self-efficacy for condom use.

Time frame: baseline up to 1 month

Other Pre-specified

Change in Self-Efficacy for HIV Prevention

Changes in Self-Efficacy will be measured using the HIV self-efficacy for HIV prevention behaviors survey. Scores range from 11-55. A higher score indicates a higher level of self-efficacy for HIV prevention behaviors.

Time frame: baseline up to 1 month

Other Pre-specified

Changes in HIV Knowledge

Change in HIV knowledge will be measured via the HIV Knowledge Scale. The score ranges from 0-12 with a higher score indicating a higher level of HIV-related knowledge.

Time frame: baseline up to 4 months

Other Pre-specified

Changes in Sexual Communication With Partner

Change in sexual communication with partner will be measured via the Partner communication Scale (Catania et al., 1995). The score ranges from 0-10 with a higher score indicating a higher level of partner communication.

Time frame: baseline up to 4 months

Other Pre-specified

Changes in STI (Sexually Transmitted Infections) Testing

Changes in STI testing will be measured as the number of participants who reported to have been tested for a STI in the last month.

Time frame: baseline up to 4 months

Other Pre-specified

Feasibility of the Intervention

Measured as the total number of sessions attended by the participants as a whole.

Time frame: baseline up to 4 months

Other Pre-specified

Mean Participant Acceptability With the Intervention Content Areas Based on a 5 Point Rating System

Participants will be asked to rate each of the 9 content area using a 5-star rating system where 1 star is the lowest and 5 points is the highest rating. A mean of all ratings will be calculated. The closer the mean is to 5.0, the higher the satisfaction with the content areas. Scores range from 9-45. A higher score indicates a higher level of acceptability.

Time frame: one-month after the baseline survey

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026